Withdrawal of Registration Statement (ammendment) (aw)
05 Aprile 2023 - 7:08PM
Edgar (US Regulatory)
![](https://content.edgar-online.com/edgar_conv_img/2023/04/05/0001213900-23-027445_image_001.jpg)
|
Jasminder Brar |
|
Vice President, Legal & IP, & General Counsel |
|
Titan Medical Inc. |
April 4, 2023 |
|
|
416.628.6875 Direct |
|
Jasminder.brar@titanmedicalinc.com |
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
USA
|
|
Request to Withdraw Post-Effective Amendment
to Form S-8
(File No. 333-267447)
Ladies and Gentlemen:
Pursuant to Rule 477 of the Securities Act of 1933, as amended (the
“Securities Act”), Titan Medical Inc. (the “Company”) hereby requests withdrawal of its Post-Effective Amendment
No. 1 to Registration Statement on Form S-8 (File No. 333-267447), together with all exhibits and amendments thereto (the “Registration
Statement”), as the Registration Statement was filed with the Securities and Exchange Commission (the “Commission”)
in an incorrect manner. The Registration Statement was originally filed with the Commission on September 16, 2022 and was filed on a post-effective
basis on April 4, 2023.
If you have any questions with respect to this request, please contact
James Guttman, our outside counsel at Dorsey & Whitney LLP at (416) 367-7376 or the undersigned at (416) 628-6875.
Sincerely,
|
TITAN MEDICAL INC. |
|
|
|
|
By
| /s/ Jasminder Brar |
|
|
Name: |
Jasminder Brar |
|
|
Title: |
Vice President, Legal & IP, & General Counsel |
Grafico Azioni Titan Medical (PK) (USOTC:TMDIF)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Titan Medical (PK) (USOTC:TMDIF)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Titan Medical Inc (PK) (OTCMarkets): 0 articoli recenti
Più Titan Medical Inc Articoli Notizie